Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nutanix Inc (Class A) | Max de Groen | Director | Sale of securities on an exchange or to another person at price $ 74.51 per share. | 04 Mar 2025 | 5,500,000 | 11,354,032 (6%) | 3% | 74.5 | 409,805,000 | Class A Common Stock |
| ADT Inc | James D. DeVries | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 3,681,118 | 3,681,118 | - | - | Employee Stock Option (right to buy) | |
| Alignment Healthcare Inc | John E. Kao | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 2,543,124 | 5,288,377 | - | 0 | Common Stock | |
| Petco Health and Wellness Co Inc (Class A) | Joel D. Anderson | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 1,727,643 | 3,220,181 | - | 0 | Class A Common Stock | |
| Whitehawk Therapeutics Inc | Caley Castelein | Director | Grant, award, or other acquisition of securities at price $ 2.40 per share. | 04 Mar 2025 | 1,666,000 | 2,165,998 | - | 2.4 | 3,998,400 | Common Stock |
| Whitehawk Therapeutics Inc | Anupam Dalal | Director | Grant, award, or other acquisition of securities at price $ 2.40 per share. | 04 Mar 2025 | 1,561,000 | 3,410,402 | - | 2.4 | 3,746,400 | Common Stock |
| Gossamer Bio Inc | Faheem Hasnain | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 1,540,000 | 1,540,000 | - | - | Stock Option (Right to Buy) | |
| Pfizer | Albert Bourla | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 1,487,296 | 1,487,296 | - | - | Stock Appreciation Rights | |
| ADT Inc | Omar Khan | EVP, Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 1,395,256 | 1,395,256 | - | - | Employee Stock Option (right to buy) | |
| Lucid Grp Inc | Marc Winterhoff | Interim CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 1,386,704 | 3,355,694 | - | 0 | Class A Common Stock | |
| Petco Health and Wellness Co Inc (Class A) | Joel D. Anderson | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 1,336,478 | 1,336,478 | - | - | Employee Stock Option (Right to Buy) | |
| Petco Health and Wellness Co Inc (Class A) | Michael F. Romanko | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 1,321,139 | 1,321,139 | - | 0 | Class A Common Stock | |
| Whitehawk Therapeutics Inc | Baiteng Zhao | Director | Grant, award, or other acquisition of securities at price $ 2.40 per share. | 04 Mar 2025 | 1,250,000 | 1,250,000 | - | 2.4 | 3,000,000 | Common Stock |
| Petco Health and Wellness Co Inc (Class A) | Joel D. Anderson | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 1,101,037 | 1,101,037 | - | - | Performance Stock Unit | |
| Alignment Healthcare Inc | Dawn Maroney | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 1,020,442 | 2,582,892 | - | 0 | Common Stock | |
| Alignment Healthcare Inc | Robert Thomas Freeman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 1,020,442 | 1,885,849 | - | 0 | Common Stock | |
| ADT Inc | Jeff Likosar | Pres Corp Dev & Trans. & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 988,142 | 988,142 | - | - | Employee Stock Option (right to buy) | |
| Lucid Grp Inc | Eric Bach | SVP, Product & Chief Engineer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 974,637 | 3,766,432 | - | 0 | Class A Common Stock | |
| Figs Inc (Class A) | Catherine Eva Spear | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 847,458 | 2,035,112 | - | 0 | Class A Common Stock | |
| Aldeyra Therapeutics Inc | Todd C. Brady | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 809,710 | 809,710 | - | - | Stock Option (right to buy) | |
| Cytek BioSciences Inc | Wenbin Jiang | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 735,294 | 735,294 | - | - | Employee Stock Option (right to buy) | |
| Whitehawk Therapeutics Inc | David Dornan | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 687,979 | 687,979 | - | - | Stock Option (right to buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 638,000 | 638,000 | - | - | Stock Option (Right to Buy) | |
| Atlas Lithium Corp | Marc Fogassa | Director, Chief Executive Officer, Ten Percent Owner | 04 Mar 2025 | 619,278 | 5,407,550 | - | 0 | Common Stock | ||
| Gossamer Bio Inc | Richard Aranda | Chief Medical Officer | 04 Mar 2025 | 572,000 | 572,000 | - | - | Stock Option (Right to Buy) | ||
| Gossamer Bio Inc | Robert Paul Smith | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 572,000 | 572,000 | - | - | Stock Option (Right to Buy) | |
| EQT | Toby Z. Rice | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 555,418 | 2,495,458 (0%) | 0% | 0 | Common Stock | |
| Alignment Healthcare Inc | John E. Kao | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.53 per share. | 04 Mar 2025 | 554,713 | 4,733,664 | - | 15.5 | 8,614,693 | Common Stock |
| Global Business Travel Grp Inc (Class A) | Paul Abbott | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 550,469 | 3,250,145 | - | 0 | Class A Common Stock | |
| Pfizer | Chris Boshoff | President, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 495,765 | 495,765 | - | - | Stock Appreciation Rights | |
| ADT Inc | David W. Smail | EVP, CLO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 494,071 | 494,071 | - | - | Employee Stock Option (right to buy) | |
| Alignment Healthcare Inc | Hakan Kardes | Chief Experience Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 474,208 | 769,652 | - | 0 | Common Stock | |
| Cytek BioSciences Inc | Wenbin Jiang | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 464,037 | 464,037 | - | - | Restricted Stock Units | |
| Braemar Hotels & Resorts Inc | Richard J. Stockton | Director, CEO and President | Other type of transaction at price $ 0.00 per share. | 04 Mar 2025 | 457,383 | 0 | - | - | Common Partnership Units | |
| Braemar Hotels & Resorts Inc | Richard J. Stockton | Director, CEO and President | Other type of transaction at price $ 0.00 per share. | 04 Mar 2025 | 457,383 | 647,098 (1%) | 1% | - | Common Stock | |
| Gossamer Bio Inc | Christian Waage | EVP, Tech Ops and Admin | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 440,000 | 440,000 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Caryn Peterson | EVP, Regulatory Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 440,000 | 440,000 | - | - | Stock Option (Right to Buy) | |
| Lucid Grp Inc | Marc Winterhoff | Interim CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.10 per share. | 04 Mar 2025 | 418,425 | 2,937,269 | - | 2.1 | 878,693 | Class A Common Stock |
| Pfizer | David M. Denton | Chief Financial Officer & EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 413,138 | 413,138 | - | - | Stock Appreciation Rights | |
| ADT Inc | Donald M. Young | EVP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 395,256 | 395,256 | - | - | Employee Stock Option (right to buy) | |
| ADT Inc | David A. Scott | EVP, Chief People & Admin. Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 395,256 | 395,256 | - | - | Employee Stock Option (right to buy) | |
| ADT Inc | DeLu Jackson | EVP, Chf Marketing & Comm Off | 04 Mar 2025 | 395,256 | 395,256 | - | - | Employee Stock Option (right to buy) | ||
| ADT Inc | Todd Dernberger | EVP and Chief Growth Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 395,256 | 395,256 | - | - | Employee Stock Option (right to buy) | |
| Nutanix Inc (Class A) | Max de Groen | Director | Other type of transaction at price $ 0.00 per share. | 04 Mar 2025 | 393,097 | 10,960,935 (6%) | 0% | - | Class A Common Stock | |
| Petco Health and Wellness Co Inc (Class A) | Michael F. Romanko | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 393,082 | 393,082 | - | - | Employee Stock Option (Right to Buy) | |
| Lucid Grp Inc | Eric Bach | SVP, Product & Chief Engineer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.10 per share. | 04 Mar 2025 | 383,376 | 3,383,056 | - | 2.1 | 805,090 | Class A Common Stock |
| Pfizer | Douglas M. Lankler | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 371,824 | 371,824 | - | - | Stock Appreciation Rights | |
| Pfizer | Aamir Malik | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 371,824 | 371,824 | - | - | Stock Appreciation Rights | |
| Pfizer | Alexandre de Germay | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 371,824 | 371,824 | - | - | Stock Appreciation Rights | |
| Adaptive biotech Corp | Chad M. Robins | Director, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 355,000 | 2,931,701 (2%) | 0% | 0 | Common Stock | |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 355,000 | 1,376,180 (1%) | 0% | 0 | Common Stock | |
| AH Realty Trust Inc | Louis S. Haddad | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Mar 2025 | 343,675 | 285,540 (0%) | 0% | 0 | Common Stock | |
| Cytek BioSciences Inc | William McCombe | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 330,882 | 330,882 | - | - | Employee Stock Option (right to buy) | |
| Xencor Inc | Bassil I. Dahiyat | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 329,236 | 329,236 | - | - | Stock Option (Right to Buy) | |
| Petco Health and Wellness Co Inc (Class A) | Michael F. Romanko | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 323,835 | 323,835 | - | - | Performance Stock Unit | |
| Figs Inc (Class A) | Sarah Oughtred | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 321,077 | 977,892 | - | 0 | Class A Common Stock | |
| Unity Software Inc | Matthew S. Bromberg | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 319,829 | 1,355,884 | - | 0 | Common Stock | |
| Enviri Corp | F. Nicholas Grasberger | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 315,383 | 315,383 | - | - | Performance Share Units | |
| ACV Auctions Inc (Class A) | George G. Chamoun | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.14 per share. | 04 Mar 2025 | 300,000 | 2,601,048 | - | 0.1 | 42,000 | Class A Common Stock |
| ACV Auctions Inc (Class A) | George G. Chamoun | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 300,000 | 952,730 | - | - | Employee Stock Option (Right to Buy) | |
| TeraWulf Inc | Paul B. Prager | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 04 Mar 2025 | 300,000 | 200,883 | - | - | Common stock, $0.001 par value per share | |
| Alignment Healthcare Inc | Robert L. Scavo | Chief Information Officer | 04 Mar 2025 | 292,000 | 728,822 | - | 0 | Common Stock | ||
| Pfizer | Michael McDermott | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 289,196 | 289,196 | - | - | Stock Appreciation Rights | |
| MBIA Inc | William C. Fallon | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 5.49 per share. | 04 Mar 2025 | 286,885 | 2,637,516 (3%) | 0% | 5.5 | 1,574,999 | Common Stock |
| Alignment Healthcare Inc | Dawn Maroney | President | Sale of securities on an exchange or to another person at price $ 15.53 per share. | 04 Mar 2025 | 278,917 | 2,303,975 | - | 15.5 | 4,331,581 | Common Stock |
| Cytek BioSciences Inc | Valerie Barnett | CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 275,735 | 275,735 | - | - | Employee Stock Option (right to buy) | |
| Lucid Grp Inc | Gagan Dhingra | SVP Finance & Accounting | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 270,730 | 1,052,117 | - | 0 | Class A Common Stock | |
| Broadcom | Mark David Brazeal | Chief Legal & Corp Affairs Ofc | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 262,500 | 584,160 (0%) | 0% | 0 | Common Stock, $0.001 par value | |
| ProPetro Holding Corp | Samuel D. Sledge | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 252,525 | 472,533 | - | - | Restricted Stock Units | |
| Enviri Corp | F. Nicholas Grasberger | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 252,223 | 252,223 | - | - | Stock Appreciation Rights | |
| Alignment Healthcare Inc | Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 15.58 per share. | 04 Mar 2025 | 250,000 | 1,635,849 | - | 15.6 | 3,895,775 | Common Stock |
| Adaptive biotech Corp | Chad M. Robins | Director, CEO and Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 247,117 | 3,061,467 (2%) | 0% | 0 | Common Stock | |
| Rayonier Advanced Materials Inc | DeLyle W. Bloomquist | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 243,079 | 518,385 (0%) | 0% | 0 | Common Stock | |
| EQT | Toby Z. Rice | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.00 per share. | 04 Mar 2025 | 241,552 | 2,253,906 (0%) | 0% | 50 | 12,077,600 | Common Stock |
| Global Business Travel Grp Inc (Class A) | Eric John Bock | See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 235,915 | 2,172,854 | - | 0 | Class A Common Stock | |
| Global Business Travel Grp Inc (Class A) | Andrew George Crawley | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 235,915 | 1,390,690 | - | 0 | Class A Common Stock | |
| Pegasystems Inc | Alan Trefler | Director, C.E.O. & Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 225,009 | 225,009 | - | - | Stock Options | |
| Unity Software Inc | Alexander Blum | SVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 225,000 | 720,648 | - | 0 | Common Stock | |
| NovoCure Ltd | Ashley Cordova | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 224,123 | 224,123 | - | - | Stock Options (Right to buy) | |
| Rimini Street Inc | Seth A. Ravin | Director, President, CEO & Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 219,605 | 219,605 | - | - | Employee Stock Options (Right to Buy) | |
| Ford Motor | Sherry House | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 219,298 | 219,298 | - | - | Ford Stock Units | |
| Alignment Healthcare Inc | Robert Thomas Freeman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 15.53 per share. | 04 Mar 2025 | 218,295 | 1,417,554 | - | 15.5 | 3,390,121 | Common Stock |
| Cytek BioSciences Inc | William McCombe | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 208,816 | 208,816 | - | - | Restricted Stock Units | |
| Rimini Street Inc | Seth A. Ravin | Director, President, CEO & Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 206,896 | 206,896 | - | - | Restricted Stock Units | |
| Pfizer | Payal Sahni | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 206,569 | 206,569 | - | - | Stock Appreciation Rights | |
| Pfizer | Andrew Baum | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 206,569 | 206,569 | - | - | Stock Appreciation Rights | |
| Petco Health and Wellness Co Inc (Class A) | John Logan Stout | Chief Merchandising Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 203,253 | 203,253 | - | 0 | Class A Common Stock | |
| Aldeyra Therapeutics Inc | Stephen G. Machatha | Chief Development Officer | 04 Mar 2025 | 202,427 | 202,427 | - | - | Stock Option (right to buy) | ||
| iHeartMedia Inc (Class A) New | Robert W. Pittman | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 1.60 per share. | 04 Mar 2025 | 200,000 | 4,241,389 (7%) | 0% | 1.6 | 320,040 | Class A Common Stock, par value $0.001 per share |
| Teva- pharma Ind Ltd (ADR) | Mark Sabag | See "Remarks" | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 183,169 | 0 | - | - | Restricted Share Units | |
| Teva- pharma Ind Ltd (ADR) | Mark Sabag | See "Remarks" | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 183,169 | 465,146 (0%) | 0% | - | Ordinary Shares | |
| Teva- pharma Ind Ltd (ADR) | Richard Daniell | Exec. VP, European Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 183,169 | 0 | - | - | Restricted Share Units | |
| Teva- pharma Ind Ltd (ADR) | Richard Daniell | Exec. VP, European Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 183,169 | 183,169 (0%) | 0% | - | Ordinary Shares | |
| Teva- pharma Ind Ltd (ADR) | Eli Kalif | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 183,169 | 437,673 (0%) | 0% | - | Ordinary Shares | |
| Teva- pharma Ind Ltd (ADR) | Eli Kalif | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 183,169 | 0 | - | - | Restricted Share Units | |
| Adaptive biotech Corp | Susan Bobulsky | Chief Commercial Officer, MRD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 180,029 | 180,029 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Julie Rubinstein | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 175,000 | 647,754 (0%) | 0% | 0 | Common Stock | |
| Cadiz Inc | Susan P. Kennedy | Director, CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Mar 2025 | 175,000 | 125,000 | - | - | Performance Rights | |
| Cytek BioSciences Inc | Valerie Barnett | CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 174,013 | 174,013 | - | - | Restricted Stock Units | |
| Apple Hospitality REIT Inc | Justin G. Knight | Director, CEO | Grant, award, or other acquisition of securities at price $ 14.48 per share. | 04 Mar 2025 | 169,405 | 1,967,625 (0%) | 0% | 14.5 | 2,452,984 | Common Shares |
| Unity Software Inc | Tomer Bar-Zeev | Director | Sale of securities on an exchange or to another person at price $ 23.40 per share. | 04 Mar 2025 | 166,667 | 3,231,479 | - | 23.4 | 3,900,008 | Common Stock |
| Adaptive biotech Corp | Sharon Benzeno | Chief Commercial Ofc Imm Med | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 165,027 | 165,027 | - | - | Stock Option (right to buy) | |
| Enviri Corp | F. Nicholas Grasberger | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 157,692 | 367,827 | - | - | Restricted Stock Units | |
| Global Business Travel Grp Inc (Class A) | Karen Williams | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 157,276 | 652,837 | - | 0 | Class A Common Stock | |
| Petco Health and Wellness Co Inc (Class A) | John Logan Stout | Chief Merchandising Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 157,233 | 157,233 | - | - | Employee Stock Option (Right to Buy) | |
| Pfizer | Lidia L. Fonseca | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 156,992 | 156,992 | - | - | Stock Appreciation Rights | |
| Pfizer | Sally Susman | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 156,992 | 156,992 | - | - | Stock Appreciation Rights | |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 156,250 | 156,250 | - | - | Employee Stock Option (right to buy) | |
| Petco Health and Wellness Co Inc (Class A) | Holly May | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 152,440 | 2,167,592 | - | 0 | Class A Common Stock | |
| Petco Health and Wellness Co Inc (Class A) | Giovanni Insana | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 152,440 | 522,428 | - | 0 | Class A Common Stock | |
| NovoCure Ltd | Ashley Cordova | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 18.19 per share. | 04 Mar 2025 | 151,181 | 355,186 (0%) | 0% | 18.2 | 2,749,982 | Ordinary Shares |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 150,024 | 150,024 | - | - | Stock Option (right to buy) | |
| NewAmsterdam Pharma Co NV | Louise Kooij | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 150,000 | 165,000 | - | - | Ordinary Shares | |
| NewAmsterdam Pharma Co NV | Louise Kooij | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 150,000 | 18,073 | - | - | Option (right to buy) | |
| NewAmsterdam Pharma Co NV | Louise Kooij | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 20.37 per share. | 04 Mar 2025 | 150,000 | 15,000 | - | 20.4 | 3,055,500 | Ordinary Shares |
| Broadcom | Charlie B. Kawwas | President, Semi Solutions Grp | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 150,000 | 232,990 (0%) | 0% | 0 | Common Stock, $0.001 par value | |
| Unity Software Inc | Anirma Gupta | SVP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 150,000 | 692,942 | - | 0 | Common Stock | |
| Unity Software Inc | Felix The | SVP Product & Technology, Grow | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 150,000 | 514,467 | - | 0 | Common Stock | |
| ADT Inc | Steven Burzo | VP, CAO & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 148,221 | 148,221 | - | - | Employee Stock Option (right to buy) | |
| World Kinect Corp | Michael J. Kasbar | Director, Chairman, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.39 per share. | 04 Mar 2025 | 145,349 | 1,164,412 (1%) | 0% | 23.4 | 3,399,713 | Common Stock |
| World Kinect Corp | Michael J. Kasbar | Director, Chairman, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 145,349 | 0 | - | - | Stock-Settled Stock Appreciation Rights | |
| Okta Inc (Class A) | Jacques Frederic Kerrest | Director | 04 Mar 2025 | 143,852 | 143,852 (0%) | 0% | 0 | Class A Common Stock | ||
| Okta Inc (Class A) | Jacques Frederic Kerrest | Director | 04 Mar 2025 | 143,852 | 0 | - | - | Class B Common Stock | ||
| Okta Inc (Class A) | Jacques Frederic Kerrest | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 143,852 | 143,852 | - | - | Class B Common Stock | |
| Okta Inc (Class A) | Jacques Frederic Kerrest | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 143,852 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Enviri Corp | Tom George Vadaketh | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 143,679 | 143,679 | - | - | Stock Appreciation Rights | |
| Mosaic | Bruce M. Bodine | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 138,648 | 138,648 | - | - | Restricted Stock Units | |
| Global Business Travel Grp Inc (Class A) | Patricia Anne Huska | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 137,617 | 1,384,551 | - | 0 | Class A Common Stock | |
| MBIA Inc | Adam T. Bergonzi | Assistant Vice President | Grant, award, or other acquisition of securities at price $ 5.49 per share. | 04 Mar 2025 | 136,612 | 843,484 (1%) | 0% | 5.5 | 750,000 | Common Stock |
| Unity Software Inc | Jarrod Yahes | SVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 130,264 | 668,380 | - | 0 | Common Stock | |
| Okta Inc (Class A) | Jacques Frederic Kerrest | Director | 04 Mar 2025 | 130,000 | 130,000 (0%) | 0% | 0 | Class A Common Stock | ||
| Okta Inc (Class A) | Jacques Frederic Kerrest | Director | 04 Mar 2025 | 130,000 | 0 | - | - | Class B Common Stock | ||
| Okta Inc (Class A) | Jacques Frederic Kerrest | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 130,000 | 130,000 | - | - | Class B Common Stock | |
| Okta Inc (Class A) | Jacques Frederic Kerrest | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 130,000 | 143,852 | - | - | Employee Stock Option (Right to Buy) | |
| Petco Health and Wellness Co Inc (Class A) | John Logan Stout | Chief Merchandising Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 129,534 | 129,534 | - | - | Performance Stock Unit | |
| Adaptive biotech Corp | Kyle Piskel | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 125,000 | 279,330 (0%) | 0% | 0 | Common Stock | |
| World Kinect Corp | Michael J. Kasbar | Director, Chairman, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.08 per share. | 04 Mar 2025 | 123,842 | 1,040,570 (1%) | 0% | 29.1 | 3,601,325 | Common Stock |
| EQT | William E. Jordan | CHIEF LEGAL & POLICY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 123,436 | 588,403 (0%) | 0% | 0 | Common Stock | |
| Adaptive biotech Corp | Susan Bobulsky | Chief Commercial Officer, MRD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 119,971 | 373,261 (0%) | 0% | 0 | Common Stock | |
| Broadcom | Kirsten M. Spears | CFO & Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 118,760 | 444,203 (0%) | 0% | 0 | Common Stock, $0.001 par value | |
| Petco Health and Wellness Co Inc (Class A) | Holly May | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 117,925 | 117,925 | - | - | Employee Stock Option (Right to Buy) | |
| Petco Health and Wellness Co Inc (Class A) | Giovanni Insana | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 117,925 | 117,925 | - | - | Employee Stock Option (Right to Buy) | |
| Rimini Street Inc | Michael L. Perica | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 114,942 | 114,942 | - | - | Restricted Stock Units | |
| ProPetro Holding Corp | Adam Munoz | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 112,233 | 225,152 | - | - | Restricted Stock Units | |
| Castle Biosciences Inc | Derek J. Maetzold | Director, Pres. & Chief Exec. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 111,948 | 111,948 | - | - | Restricted Stock Units | |
| Tevogen Bio Holdings Inc | Neal Flomenberg | See Remarks | Sale of securities on an exchange or to another person at price $ 1.21 per share. | 04 Mar 2025 | 110,659 | 4,129,004 | - | 1.2 | 133,897 | Common Stock |
| Adaptive biotech Corp | Sharon Benzeno | Chief Commercial Ofc Imm Med | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 109,973 | 437,388 (0%) | 0% | 0 | Common Stock | |
| Xencor Inc | Bassil I. Dahiyat | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 109,745 | 485,135 (0%) | 0% | 0 | Common Stock | |
| Fox Factory Holding Corp | Michael C. Dennison | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 103,290 | 224,786 (0%) | 0% | 0 | Common Stock | |
| Adaptive biotech Corp | Chad M. Robins | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 7.64 per share. | 04 Mar 2025 | 102,218 | 2,959,249 (2%) | 0% | 7.6 | 780,946 | Common Stock |
| American International | Peter S. Zaffino | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 82.94 per share. | 04 Mar 2025 | 101,449 | 640,966 (0%) | 0% | 82.9 | 8,414,180 | Common Stock |
| Lucid Grp Inc | Gagan Dhingra | SVP Finance & Accounting | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.10 per share. | 04 Mar 2025 | 101,185 | 950,932 | - | 2.1 | 212,489 | Class A Common Stock |
| East West Bancorp Inc | Dominic Ng | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 100,560 | 1,056,515 (0%) | 0% | 0 | Common Stock | |
| Franklin Resources Inc | Charles B. Johnson | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 19.57 per share. | 04 Mar 2025 | 100,000 | 89,375,067 (17%) | 0% | 19.6 | 1,957,000 | Common Stock, par value $.10 |
| Adaptive biotech Corp | Francis Lo | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 99,976 | 353,721 (0%) | 0% | 0 | Common Stock | |
| Cytek BioSciences Inc | Ming Yan | Director, CHIEF TECHNOLOGY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 98,607 | 98,607 | - | - | Restricted Stock Units | |
| Petco Health and Wellness Co Inc (Class A) | Holly May | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 97,151 | 97,151 | - | - | Performance Stock Unit | |
| Petco Health and Wellness Co Inc (Class A) | Giovanni Insana | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 97,151 | 97,151 | - | - | Performance Stock Unit | |
| Callaway Golf Co | Oliver G. Brewer | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Mar 2025 | 95,715 | 809,397 (0%) | 0% | 0 | Common Stock | |
| Rayonier Advanced Materials Inc | DeLyle W. Bloomquist | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.48 per share. | 04 Mar 2025 | 95,652 | 422,733 (0%) | 0% | 7.5 | 715,477 | Common Stock |
| MBIA Inc | Daniel M. Avitabile | Assistant Vice President | Grant, award, or other acquisition of securities at price $ 5.49 per share. | 04 Mar 2025 | 95,628 | 580,085 (0%) | 0% | 5.5 | 524,998 | Common Stock |
| MBIA Inc | Christopher H. Young | Assistant Vice President | Grant, award, or other acquisition of securities at price $ 5.49 per share. | 04 Mar 2025 | 95,628 | 581,102 (0%) | 0% | 5.5 | 524,998 | Common Stock |
| Advance Auto Parts Inc | Shane M. OKelly | Director, Director, President and CEO | Grant, award, or other acquisition of securities at price $ 34.58 per share. | 04 Mar 2025 | 93,985 | 181,621 (0%) | 0% | 34.6 | 3,250,001 | Common Stock |
| Ligand Pharma Inc (Class B) | Todd C. Davis | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 93,476 | 93,476 | - | - | Employee Stock Option (right to buy) | |
| HSBC Holdings PLC (ADR) | Georges Elhedery | Executive Director,Chief Executive Officer and Chief Financial Officer | 04 Mar 2025 | 92,447 | 1,058,464 (0%) | 0% | 0 | Ords 0.50p | ||
| Ranpak Holdings Corp (Class A) | Omar M. Asali | Director, CEO & Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 92,026 | 2,685,259 (4%) | 0% | 0 | Class A common stock | |
| Cytek BioSciences Inc | Philippe Busque | SVP, GLOBAL SALES AND SERVICES | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 91,911 | 91,911 | - | - | Employee Stock Option (right to buy) | |
| Wave Life Sciences Ltd | Chandra Vargeese | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 04 Mar 2025 | 91,754 | 362,687 (1%) | 0% | 2.5 | 227,550 | Ordinary Shares |
| Rimini Street Inc | Michael L. Perica | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 91,502 | 91,502 | - | - | Employee Stock Options (Right to Buy) | |
| Monster Beverage | Emelie C. Tirre | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 55.38 per share. | 04 Mar 2025 | 91,316 | 76,201 (0%) | 0% | 55.4 | 5,057,080 | Common Stock |
| Zoom Video Comm Inc (Class A) | Eric S. Yuan | Director, Chief Executive Officer | 04 Mar 2025 | 91,133 | 21,620,585 | - | - | Class B Common Stock | ||
| Zoom Video Comm Inc (Class A) | Eric S. Yuan | Director, Chief Executive Officer | 04 Mar 2025 | 91,133 | 91,133 (0%) | 0% | 0 | Class A Common Stock | ||
| Enviri Corp | Tom George Vadaketh | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 89,829 | 89,829 | - | - | Performance Share Units | |
| Enviri Corp | Tom George Vadaketh | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 89,829 | 322,838 | - | - | Restricted Stock Units | |
| Xencor Inc | John R. Desjarlais | SR. VICE PRESIDENT & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 89,552 | 89,552 | - | - | Stock Option (Right to Buy) | |
| Tevogen Bio Holdings Inc | Neal Flomenberg | See Remarks | Sale of securities on an exchange or to another person at price $ 1.10 per share. | 04 Mar 2025 | 88,519 | 4,040,485 | - | 1.1 | 97,371 | Common Stock |
| Alignment Healthcare Inc | Hakan Kardes | Chief Experience Officer | Sale of securities on an exchange or to another person at price $ 15.53 per share. | 04 Mar 2025 | 86,659 | 682,993 | - | 15.5 | 1,345,814 | Common Stock |
| Monopar Therapeutics Inc | Chandler D. Robinson | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 85,759 | 85,759 | - | - | Stock Options | |
| Cosmos Health Inc | Grigorios Siokas | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.53 per share. | 04 Mar 2025 | 85,714 | 4,115,302 | - | 0.5 | 45,000 | Common Stock, par value $.001 |
| General Dynamics | Phebe N. Novakovic | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 84,160 | 84,160 | - | - | Stock Options | |
| Surgery Partners Inc | J. Eric Evans | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 23.80 per share. | 04 Mar 2025 | 84,033 | 644,731 (1%) | 0% | 23.8 | 1,999,985 | Common Stock |
| Rayonier Advanced Materials Inc | Marcus J. Moeltner | CFO and SVP, Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 82,649 | 204,662 (0%) | 0% | 0 | Common Stock | |
| EQT | Robert R. Wingo | EVP CORP VENTURES & MIDSTREAM | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 82,298 | 295,055 (0%) | 0% | 0 | Common Stock | |
| Varonis Systems Inc | Yakov Faitelson | Director, CEO, President, Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.97 per share. | 04 Mar 2025 | 81,986 | 1,734,966 (5%) | 0% | 43.0 | 3,522,938 | Common Stock, par value $0.001 per share |
| NovoCure Ltd | Uri Weinberg | Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 81,499 | 81,499 | - | - | Stock Options (Right to buy) | |
| NovoCure Ltd | Francis Leonard | EVP, Pres., Novocure Oncology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 81,499 | 81,499 | - | - | Stock Options (Right to buy) | |
| NovoCure Ltd | Barak Ben Arye | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 81,499 | 81,499 | - | - | Stock Options (Right to buy) | |
| NovoCure Ltd | Michal Nath Puri | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 81,499 | 81,499 | - | - | Stock Options (Right to buy) | |
| NovoCure Ltd | Nicholas Leupin | Chief Medical Officer | 04 Mar 2025 | 81,499 | 81,499 | - | - | Stock Options (Right to buy) | ||
| NovoCure Ltd | Mukund Paravasthu | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 81,499 | 81,499 | - | - | Stock Options (Right to buy) | |
| NovoCure Ltd | Christoph Brackmann | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 81,499 | 81,499 | - | - | Stock Options (Right to buy) | |
| Adaptive biotech Corp | Chad M. Robins | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 6.98 per share. | 04 Mar 2025 | 81,206 | 2,850,495 (2%) | 0% | 7.0 | 566,818 | Common Stock |
| Monopar Therapeutics Inc | Chandler D. Robinson | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 79,899 | 104,777 | - | - | Restricted Stock Units | |
| Enviri Corp | Russell C. Hochman | SVP, GC, CCO and Corp. Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 79,559 | 79,559 | - | - | Stock Appreciation Rights | |
| Spire Global Inc (Class A) | Peter Platzer | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 10.02 per share. | 04 Mar 2025 | 78,933 | 1,761,424 | - | 10.0 | 790,719 | Class A Common Stock |
| Okta Inc (Class A) | Jacques Frederic Kerrest | Director | Sale of securities on an exchange or to another person at price $ 112.50 per share. | 04 Mar 2025 | 78,852 | 0 (0%) | 0% | 112.5 | 8,870,850 | Class A Common Stock |
| Axalta Coating Systems Ltd | Chris Villavarayan | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 78,740 | 78,740 | - | - | Restricted Stock Units | |
| Apple Hospitality REIT Inc | Justin G. Knight | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 78,551 | 2,046,176 (0%) | 0% | 0 | Common Shares | |
| Ridgepost Capital Inc | Amanda N. Coussens | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 76,972 | 0 | - | - | Restricted Stock Units | |
| Ridgepost Capital Inc | Amanda N. Coussens | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 76,972 | 107,044 | - | - | Class A Common Stock | |
| NuScale Power Corp (Class A) | John L. Hopkins | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 14.52 per share. | 04 Mar 2025 | 76,949 | 34,675 | - | 14.5 | 1,117,299 | Class A Common Stock |
| Apple Hospitality REIT Inc | Justin G. Knight | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.48 per share. | 04 Mar 2025 | 76,401 | 1,969,775 (0%) | 0% | 14.5 | 1,106,286 | Common Shares |
| Hilton Grand Vacations Inc | Mark D. Wang | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 75,731 | 793,994 (0%) | 0% | 0 | Common Stock | |
| Zoom Video Comm Inc (Class A) | Eric S. Yuan | Director, Chief Executive Officer | 04 Mar 2025 | 75,531 | 75,531 (0%) | 0% | 0 | Class A Common Stock | ||
| Zoom Video Comm Inc (Class A) | Eric S. Yuan | Director, Chief Executive Officer | 04 Mar 2025 | 75,531 | 21,711,718 | - | - | Class B Common Stock | ||
| Wave Life Sciences Ltd | Chandra Vargeese | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 75,332 | 0 | - | - | Share Option (right to buy) | |
| Reddit Inc (Class A) | Benjamin Lee | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 75,000 | 249,500 | - | - | Stock Option (Right to Buy) | |
| Reddit Inc (Class A) | Benjamin Lee | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.92 per share. | 04 Mar 2025 | 75,000 | 207,300 | - | 7.9 | 594,000 | Class A Common Stock |
| Acushnet Holdings Corp | David Maher | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 72,993 | 908,943 (1%) | 0% | 0 | Common Stock | |
| ONE Grp Hospitality Inc | Emanuel P.N. Hilario | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 72,364 | 1,906,190 (6%) | 0% | 0 | Common Stock | |
| Teleflex Incorporated | Liam J. Kelly | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 71,983 | 71,983 | - | - | Stock Option / (Right to Buy) | |
| Longeveron Inc (Class A) | Joshua M. Hare | Director, Chief Scientific Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 71,254 | 71,254 | - | - | Stock Option (right to buy) | |
| Apple Hospitality REIT Inc | Nelson G. Knight | President Real Estate & Invest | Grant, award, or other acquisition of securities at price $ 14.48 per share. | 04 Mar 2025 | 70,736 | 946,984 (0%) | 0% | 14.5 | 1,024,257 | Common Shares |
| Apple Hospitality REIT Inc | Elizabeth S. Perkins | SVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 14.48 per share. | 04 Mar 2025 | 70,056 | 359,655 (0%) | 0% | 14.5 | 1,014,411 | Common Shares |
| SEACOR Marine Holdings Inc | Jesus Llorca | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.26 per share. | 04 Mar 2025 | 69,782 | 508,345 (2%) | 0% | 5.3 | 367,053 | Common Stock |
| Unity Software Inc | Tomer Bar-Zeev | Director | Sale of securities on an exchange or to another person at price $ 25.15 per share. | 04 Mar 2025 | 69,670 | 3,161,809 | - | 25.2 | 1,752,201 | Common Stock |
| Enviri Corp | Jeffrey A. Beswick | SVP & Grp. Pres., Clean Earth | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 68,794 | 68,794 | - | - | Stock Appreciation Rights | |
| Zoom Video Comm Inc (Class A) | Eric S. Yuan | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 75.37 per share. | 04 Mar 2025 | 68,397 | 0 (0%) | 0% | 75.4 | 5,155,403 | Class A Common Stock |
| Hyatt Hotels Corp (Class A) | Mark S. Hoplamazian | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 66,807 | 690,363 (1%) | 0% | 0 | Class A Common Stock | |
| ACI Worldwide Inc | Thomas W. Warsop | Director, Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 66,806 | 334,098 (0%) | 0% | 0 | Common Stock | |
| Spire Global Inc (Class A) | Peter Platzer | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 10.81 per share. | 04 Mar 2025 | 66,667 | 1,694,757 | - | 10.8 | 720,997 | Class A Common Stock |
| Xencor Inc | Celia E. Eckert | SVP, GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 65,847 | 65,847 | - | - | Stock Option (Right to Buy) | |
| Xencor Inc | Bart Jan Cornelissen | SR. VICE PRESIDENT & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 65,847 | 65,847 | - | - | Stock Option (Right to Buy) | |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 44.53 per share. | 04 Mar 2025 | 65,344 | 848,422 | - | 44.5 | 2,909,899 | Class A Common Stock |
| Apple Hospitality REIT Inc | Karen C. Gallagher | SVP & Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 14.48 per share. | 04 Mar 2025 | 65,295 | 360,894 (0%) | 0% | 14.5 | 945,472 | Common Shares |
| SEACOR Marine Holdings Inc | John Gellert | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.26 per share. | 04 Mar 2025 | 65,205 | 992,575 (4%) | 0% | 5.3 | 342,978 | Common Stock |
| Q2 Holdings Inc | Matthew P. Flake | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 80.89 per share. | 04 Mar 2025 | 65,063 | 510,648 (1%) | 0% | 80.9 | 5,262,946 | Common Stock |
| Okta Inc (Class A) | Jacques Frederic Kerrest | Director | Sale of securities on an exchange or to another person at price $ 106.50 per share. | 04 Mar 2025 | 65,000 | 0 (0%) | 0% | 106.5 | 6,922,500 | Class A Common Stock |
| Okta Inc (Class A) | Jacques Frederic Kerrest | Director | Sale of securities on an exchange or to another person at price $ 103.50 per share. | 04 Mar 2025 | 65,000 | 65,000 (0%) | 0% | 103.5 | 6,727,500 | Class A Common Stock |
| Okta Inc (Class A) | Jacques Frederic Kerrest | Director | Sale of securities on an exchange or to another person at price $ 109.50 per share. | 04 Mar 2025 | 65,000 | 78,852 (0%) | 0% | 109.5 | 7,117,500 | Class A Common Stock |
| Pegasystems Inc | Kenneth Stillwell | COO, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 64,289 | 64,289 | - | - | Stock Options | |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 44.54 per share. | 04 Mar 2025 | 64,262 | 1,340,372 | - | 44.5 | 2,862,499 | Class A Common Stock |
| Gates Industrial Corp PLC | Ivo Jurek | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 63,890 | 525,523 | - | - | Time-Based Restricted Stock Units | |
| Gates Industrial Corp PLC | Ivo Jurek | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 63,890 | 1,054,424 (0%) | 0% | 0 | Ordinary Shares | |
| Ridgepost Capital Inc | Nell M. Blatherwick | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 63,330 | 121,274 | - | 0 | Class A Common Stock | |
| Ridgepost Capital Inc | Nell M. Blatherwick | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 63,330 | 388,330 | - | 0 | Class A Common Stock | |
| Ridgepost Capital Inc | Nell M. Blatherwick | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 63,330 | 0 | - | - | Restricted Stock Unit | |
| Ridgepost Capital Inc | Nell M. Blatherwick | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 63,330 | 0 | - | - | Restricted Stock Unit | |
| EQT | Lesley Evancho | CHIEF HUMAN RESOURCES OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 62,598 | 227,821 (0%) | 0% | 0 | Common Stock | |
| EQT | Richard Anthony Duran | CHIEF INFORMATION OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 61,718 | 293,976 (0%) | 0% | 0 | Common Stock | |
| Marriott Vacations Worldwide Corp | John E. Geller | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 60,420 | 60,420 | - | - | Stock Appreciation Right | |
| Treace Medical Concepts Inc | John Treace | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 8.73 per share. | 04 Mar 2025 | 60,000 | 6,796,190 | - | 8.7 | 524,064 | Common Stock |
| Cogent Comm Holdings Inc | David Schaeffer | Director, CHAIRMAN, CEO, AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 71.77 per share. | 04 Mar 2025 | 60,000 | 4,444,038 (9%) | 0% | 71.8 | 4,305,978 | common stock |
| Crexendo Inc | Jeffrey G. Korn | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 60,000 | 60,000 | - | - | Restricted Stock Units | |
| Crexendo Inc | Doug Gaylor | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 60,000 | 60,000 | - | - | Restricted Stock Units | |
| Crexendo Inc | Ronald Vincent | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 60,000 | 60,000 | - | - | Restricted Stock Units | |
| ONE Grp Hospitality Inc | Emanuel P.N. Hilario | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 2.98 per share. | 04 Mar 2025 | 58,725 | 1,833,826 (6%) | 0% | 3.0 | 175,001 | Common Stock |
| Alignment Healthcare Inc | Christopher J. Joyce | Chief Legal and Admin. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 58,400 | 422,845 | - | 0 | Common Stock | |
| Alignment Healthcare Inc | Hyong Kim | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 58,400 | 528,896 | - | 0 | Common Stock | |
| Cytek BioSciences Inc | Philippe Busque | SVP, GLOBAL SALES AND SERVICES | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 58,004 | 58,004 | - | - | Restricted Stock Units | |
| Ford Motor | Sherry House | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 57,409 | 127,982 (0%) | 0% | - | Common Stock, $0.01 par value | |
| Ford Motor | Sherry House | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 57,409 | 116,558 | - | - | Ford Stock Units | |
| Teva- pharma Ind Ltd (ADR) | Richard Daniell | Exec. VP, European Commercial | Sale of securities on an exchange or to another person at price $ 15.73 per share. | 04 Mar 2025 | 56,385 | 126,784 (0%) | 0% | 15.7 | 887,195 | Ordinary Shares |
| ProPetro Holding Corp | John J. Mitchell | Gen. Counsel & Corp. Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 56,117 | 108,310 | - | - | Restricted Stock Units | |
| ProPetro Holding Corp | Shelby K. Fietz | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 56,117 | 326,673 | - | - | Restricted Stock Units | |
| Arch Capital | Nicolas Papadopoulo | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 56,073 | 56,073 | - | - | Stock Option (right to buy) | |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 6.99 per share. | 04 Mar 2025 | 56,053 | 1,279,524 (1%) | 0% | 7.0 | 391,810 | Common Stock |
| Macerich Co. | Jackson Hsieh | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 17.75 per share. | 04 Mar 2025 | 56,000 | 226,500 (0%) | 0% | 17.7 | 993,832 | Common Stock |
| Alignment Healthcare Inc | Robert L. Scavo | Chief Information Officer | 04 Mar 2025 | 55,403 | 673,419 | - | 15.5 | 860,409 | Common Stock | |
| NovoCure Ltd | Uri Weinberg | Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 18.19 per share. | 04 Mar 2025 | 54,975 | 221,218 (0%) | 0% | 18.2 | 999,995 | Ordinary Shares |
| NovoCure Ltd | Francis Leonard | EVP, Pres., Novocure Oncology | Grant, award, or other acquisition of securities at price $ 18.19 per share. | 04 Mar 2025 | 54,975 | 198,648 (0%) | 0% | 18.2 | 999,995 | Ordinary Shares |
| NovoCure Ltd | Barak Ben Arye | General Counsel | Grant, award, or other acquisition of securities at price $ 18.19 per share. | 04 Mar 2025 | 54,975 | 173,696 (0%) | 0% | 18.2 | 999,995 | Ordinary Shares |
| NovoCure Ltd | Michal Nath Puri | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 18.19 per share. | 04 Mar 2025 | 54,975 | 163,681 (0%) | 0% | 18.2 | 999,995 | Ordinary Shares |
| NovoCure Ltd | Nicholas Leupin | Chief Medical Officer | 04 Mar 2025 | 54,975 | 105,108 (0%) | 0% | 18.2 | 999,995 | Ordinary Shares | |
| NovoCure Ltd | Mukund Paravasthu | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 18.19 per share. | 04 Mar 2025 | 54,975 | 84,148 (0%) | 0% | 18.2 | 999,995 | Ordinary Shares |
| NovoCure Ltd | Christoph Brackmann | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 18.19 per share. | 04 Mar 2025 | 54,975 | 121,150 (0%) | 0% | 18.2 | 999,995 | Ordinary Shares |
| Zoom Video Comm Inc (Class A) | Eric S. Yuan | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 75.34 per share. | 04 Mar 2025 | 54,753 | 0 (0%) | 0% | 75.3 | 4,125,086 | Class A Common Stock |
| Aware Inc | Brent P. Johnstone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 54,698 | 54,698 | - | - | Unrestricted Stock Award | |
| Rayonier Advanced Materials Inc | Joshua C. Hicks | SVP, High Purity Cellulose | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 54,013 | 263,100 (0%) | 0% | 0 | Common Stock | |
| FMC Corp | Pierre R. Brondeau | Director, Chairman and CEO | Purchase of securities on an exchange or from another person at price $ 35.90 per share. | 04 Mar 2025 | 54,000 | 298,439 (0%) | 0% | 35.9 | 1,938,449 | Common Stock |
| Sinclair Inc (Class A) | David D. Smith | Director, Executive Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.73 per share. | 04 Mar 2025 | 53,126 | 698,690 (1%) | 0% | 13.7 | 729,287 | Class A Common Stock |
| Aware Inc | Brian D. Connolly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 51,342 | 51,342 | - | - | Unrestricted Stock Award | |
| Northpointe Bancshares Inc | Robert W. De Vlieger | Director | Sale of securities on an exchange or to another person at price $ 13.56 per share. | 04 Mar 2025 | 50,819 | 760,828 | - | 13.6 | 689,106 | Common Stock |
| Teva- pharma Ind Ltd (ADR) | Richard D. Francis | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 50,223 | 295,556 (0%) | 0% | - | Ordinary Shares | |
| Teva- pharma Ind Ltd (ADR) | Richard D. Francis | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 50,223 | 150,669 | - | - | Restricted Share Units | |
| Ameresco Inc (Class A) | George Sakellaris | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 9.74 per share. | 04 Mar 2025 | 50,000 | 953,638 (3%) | 0% | 9.7 | 487,000 | Class A Common Stock |
| Ameresco Inc (Class A) | George Sakellaris | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 9.96 per share. | 04 Mar 2025 | 50,000 | 903,638 (3%) | 0% | 10.0 | 498,000 | Class A Common Stock |
| Hayward Holdings Inc | Kevin P. Holleran | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 14.08 per share. | 04 Mar 2025 | 50,000 | 623,540 | - | 14.1 | 704,115 | Common Stock |
| Hayward Holdings Inc | Kevin P. Holleran | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.40 per share. | 04 Mar 2025 | 50,000 | 673,540 | - | 1.4 | 70,000 | Common Stock |
| Hayward Holdings Inc | Kevin P. Holleran | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 50,000 | 3,038,571 | - | - | Stock Options (Right to Buy) | |
| Life360 Inc | Charles Prober | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.18 per share. | 04 Mar 2025 | 50,000 | 152,742 | - | 11.2 | 559,000 | Common stock |
| Life360 Inc | Charles Prober | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 50,000 | 142,752 | - | - | Stock Option (right to buy) | |
| Roblox Corp (Class A) | Michael Guthrie | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 50,000 | 1,072,390 | - | - | Stock Option (Right to Buy) | |
| Roblox Corp (Class A) | Michael Guthrie | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.53 per share. | 04 Mar 2025 | 50,000 | 445,465 | - | 0.5 | 26,500 | Class A Common Stock |
| Zai Lab Ltd (ADR) | Samantha Du | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 50,000 | 439,165 | - | - | Stock Options (Right to Buy) | |
| Zai Lab Ltd (ADR) | Samantha Du | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 04 Mar 2025 | 50,000 | 544,117 (1%) | 0% | 0.6 | 30,000 | American Depositary Shares |
| Enviri Corp | Russell C. Hochman | SVP, GC, CCO and Corp. Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 49,741 | 115,290 | - | - | Restricted Stock Units | |
| Enviri Corp | Russell C. Hochman | SVP, GC, CCO and Corp. Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 49,741 | 49,741 | - | - | Performance Share Units | |
| Rayonier Advanced Materials Inc | James L. Posze | CAO & SVP, Human Resources | 04 Mar 2025 | 49,590 | 266,283 (0%) | 0% | 0 | Common Stock | ||
| Life360 Inc | Charles Prober | Director | Sale of securities on an exchange or to another person at price $ 41.51 per share. | 04 Mar 2025 | 49,500 | 103,242 | - | 41.5 | 2,054,745 | Common stock |
| Enviri Corp | Jennifer O. Kozak | Senior Vice President & CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 48,776 | 48,776 | - | - | Stock Appreciation Rights | |
| Clean Energy Fuels Corp | Barclay F. Corbus | SVP, STRATEGIC DEVELOPMENT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.88 per share. | 04 Mar 2025 | 48,660 | 1,166,548 (0%) | 0% | 1.9 | 91,481 | Common Stock |
| EQT | William E. Jordan | CHIEF LEGAL & POLICY OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.00 per share. | 04 Mar 2025 | 48,573 | 539,830 (0%) | 0% | 50 | 2,428,650 | Common Stock |
| East West Bancorp Inc | Dominic Ng | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 90.30 per share. | 04 Mar 2025 | 48,201 | 1,008,314 (0%) | 0% | 90.3 | 4,352,550 | Common Stock |
| Aware Inc | Peter R. Faubert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 47,987 | 47,987 | - | - | Unrestriced Stock Award | |
| Perella Weinberg Partners | Andrew Bednar | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.24 per share. | 04 Mar 2025 | 47,967 | 676,436 | - | 22.2 | 1,066,786 | Class A Common Stock |
| Castle Biosciences Inc | Frank Stokes | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 47,838 | 47,838 | - | - | Restricted Stock Units | |
| Castle Biosciences Inc | Kristen Oelschlager M. | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 47,838 | 47,838 | - | - | Restricted Stock Units | |
| Castle Biosciences Inc | Tobin W. Juvenal | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 47,838 | 47,838 | - | - | Restricted Stock Units | |
| nLIGHT Inc | William Gossman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 47,313 | 0 | - | - | Stock Option (Right to Buy) | |
| nLIGHT Inc | William Gossman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.75 per share. | 04 Mar 2025 | 47,313 | 91,833 (0%) | 0% | 0.8 | 35,485 | Common Stock |
| Aware Inc | Gary Evee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 46,980 | 46,980 | - | - | Unrestricted Stock Award | |
| Payoneer Global Inc | Itai Perry | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 8.11 per share. | 04 Mar 2025 | 46,923 | 198,784 | - | 8.1 | 380,546 | Common Stock |
| General Dynamics | Phebe N. Novakovic | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 46,675 | 809,843 (0%) | 0% | 0 | Common Stock | |
| Monster Beverage | Emelie C. Tirre | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 46,650 | 0 | - | - | Employee Stock Option (right to buy) | |
| Monster Beverage | Emelie C. Tirre | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.84 per share. | 04 Mar 2025 | 46,650 | 139,517 (0%) | 0% | 29.8 | 1,392,036 | Common Stock |
| Zai Lab Ltd (ADR) | Samantha Du | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 46,389 | 392,776 | - | - | Stock Options (Right to Buy) | |
| Zai Lab Ltd (ADR) | Samantha Du | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 04 Mar 2025 | 46,389 | 540,506 (1%) | 0% | 0.6 | 27,833 | American Depositary Shares |
| MBIA Inc | Joseph R. Schachinger | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 5.49 per share. | 04 Mar 2025 | 45,537 | 203,257 (0%) | 0% | 5.5 | 249,998 | Common Stock |
| Unity Software Inc | Mark Barrysmith | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 45,000 | 484,862 | - | 0 | Common Stock | |
| Aware Inc | John S. Stafford | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 44,631 | 44,631 | - | - | Unrestricted Stock Award | |
| Clarivate PLC | Jonathan Mark Collins | Executive Vice President/CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 44,311 | 713,081 | - | 0 | Ordinary Shares | |
| Perella Weinberg Partners | Dietrich Becker | Director, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.24 per share. | 04 Mar 2025 | 44,044 | 546,022 | - | 22.2 | 979,539 | Class A Common Stock |
| HSBC Holdings PLC (ADR) | Georges Elhedery | Executive Director,Chief Executive Officer and Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 9.26 per share. | 04 Mar 2025 | 43,451 | 1,015,013 (0%) | 0% | 9.3 | 402,356 | Ords 0.50p |
| Monopar Therapeutics Inc | Andrew J. Cittadine | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 43,445 | 43,445 | - | - | Stock Options | |
| ITT Inc | Luca Savi | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 43,395 | 363,875 (0%) | 0% | 0 | Common Stock | |
| Mosaic | Luciano Siani Pires | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 43,328 | 43,328 | - | - | Restricted Stock Units | |
| SLR Investment Corp | Michael S. Gross | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 17.64 per share. | 04 Mar 2025 | 43,200 | 3,848,060 (9%) | 0% | 17.6 | 762,048 | Common Stock |
| SLR Investment Corp | Bruce J. Spohler | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 17.64 per share. | 04 Mar 2025 | 43,200 | 3,686,336 (8%) | 0% | 17.6 | 762,048 | Common Stock |
| SLR Investment Corp | Michael S. Gross | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 17.64 per share. | 04 Mar 2025 | 43,200 | 3,848,060 (9%) | 0% | 17.6 | 762,048 | Common Stock |
| SLR Investment Corp | Bruce J. Spohler | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 17.64 per share. | 04 Mar 2025 | 43,200 | 3,686,336 (8%) | 0% | 17.6 | 762,048 | Common Stock |
| Enviri Corp | Jeffrey A. Beswick | SVP & Grp. Pres., Clean Earth | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 43,010 | 43,010 | - | - | Performance Share Units | |
| Enviri Corp | Jeffrey A. Beswick | SVP & Grp. Pres., Clean Earth | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 43,010 | 62,568 | - | - | Restricted Stock Units | |
| Grindr Inc (Class A) | Vandana Mehta-Krantz | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.24 per share. | 04 Mar 2025 | 42,861 | 743,954 | - | 18.2 | 781,785 | Common Stock |
| Hippo Holdings Inc | Stewart Ellis | CFO/ Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 42,794 | 346,545 | - | 0 | Common Stock | |
| Apple Hospitality REIT Inc | Rachel S. Labrecque | SVP & Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 14.48 per share. | 04 Mar 2025 | 42,752 | 233,389 (0%) | 0% | 14.5 | 619,049 | Common Shares |
| Apple Hospitality REIT Inc | Matthew P. Rash | SVP & Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 14.48 per share. | 04 Mar 2025 | 42,752 | 246,840 (0%) | 0% | 14.5 | 619,049 | Common Shares |
| Adaptive biotech Corp | Sharon Benzeno | Chief Commercial Ofc Imm Med | Sale of securities on an exchange or to another person at price $ 6.98 per share. | 04 Mar 2025 | 41,600 | 395,788 (0%) | 0% | 7.0 | 290,368 | Common Stock |
| Septerna Inc | Alan Ezekowitz | Director | Purchase of securities on an exchange or from another person at price $ 6.00 per share. | 04 Mar 2025 | 41,355 | 104,101 | - | 6 | 248,130 | Common Stock |
| Adaptive biotech Corp | Harlan Robins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 6.98 per share. | 04 Mar 2025 | 40,603 | 1,335,577 (1%) | 0% | 7.0 | 283,409 | Common Stock |
| Monopar Therapeutics Inc | Andrew J. Cittadine | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 40,581 | 51,655 | - | - | Restricted Stock Units | |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 43.64 per share. | 04 Mar 2025 | 40,214 | 1,404,634 | - | 43.6 | 1,754,979 | Class A Common Stock |
| Adaptive biotech Corp | Julie Rubinstein | President and COO | Sale of securities on an exchange or to another person at price $ 6.98 per share. | 04 Mar 2025 | 40,044 | 607,710 (0%) | 0% | 7.0 | 279,507 | Common Stock |
| Northern Oil and Gas Inc | Bahram Akradi | Director | Purchase of securities on an exchange or from another person at price $ 28.03 per share. | 04 Mar 2025 | 40,000 | 1,662,016 (0%) | 0% | 28.0 | 1,121,360 | Common Stock |
| Sprout Social Inc (Class A) | Justyn Howard | Director, Executive Chair, Ten Percent Owner | 04 Mar 2025 | 40,000 | 47,417 (0%) | 0% | 0 | Class A Common Stock | ||
| Sprout Social Inc (Class A) | Justyn Howard | Director, Executive Chair, Ten Percent Owner | 04 Mar 2025 | 40,000 | 1,961,190 | - | - | Class B Common Stock | ||
| Collegium pharma Inc | Shirley R. Kuhlmann | EVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.03 per share. | 04 Mar 2025 | 40,000 | 194,204 (0%) | 0% | 24.0 | 961,200 | Common Stock |
| Collegium pharma Inc | Shirley R. Kuhlmann | EVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 40,000 | 0 | - | - | Stock Option (Right to Purchase) | |
| Collegium pharma Inc | Shirley R. Kuhlmann | EVP and General Counsel | Sale of securities on an exchange or to another person at price $ 28.08 per share. | 04 Mar 2025 | 40,000 | 154,204 (0%) | 0% | 28.1 | 1,123,160 | Common Stock |
| Grid Dynamics Holdings Inc (Class A) | Leonard Livschitz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 18.66 per share. | 04 Mar 2025 | 40,000 | 3,199,081 | - | 18.7 | 746,400 | Common Stock |
| MBIA Inc | William C. Fallon | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.49 per share. | 04 Mar 2025 | 39,658 | 2,350,631 (3%) | 0% | 5.5 | 217,722 | Common Stock |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 43.62 per share. | 04 Mar 2025 | 38,793 | 913,766 | - | 43.6 | 1,692,259 | Class A Common Stock |
| Enviri Corp | Christophe Reitemeier N. | President-Harsco Environmental | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 37,881 | 37,881 | - | - | Stock Appreciation Rights | |
| Septerna Inc | Alan Ezekowitz | Director | Purchase of securities on an exchange or from another person at price $ 5.82 per share. | 04 Mar 2025 | 37,835 | 62,746 | - | 5.8 | 220,260 | Common Stock |
| OneSpan Inc | Victor T. Limongelli | CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 37,788 | 37,788 | - | - | Restrict Stock Units | |
| Zai Lab Ltd (ADR) | Samantha Du | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 33.55 per share. | 04 Mar 2025 | 37,752 | 499,700 (0%) | 0% | 33.6 | 1,266,580 | American Depositary Shares |
| ITT Inc | Luca Savi | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 37,250 | 320,480 (0%) | 0% | 0 | Common Stock | |
| Sprout Social Inc (Class A) | Justyn Howard | Director, Executive Chair, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 26.28 per share. | 04 Mar 2025 | 37,035 | 10,382 (0%) | 0% | 26.3 | 973,428 | Class A Common Stock |
| SLR Investment Corp | Michael S. Gross | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 17.51 per share. | 04 Mar 2025 | 36,822 | 3,884,882 (9%) | 0% | 17.5 | 644,753 | Common Stock |
| SLR Investment Corp | Bruce J. Spohler | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 17.51 per share. | 04 Mar 2025 | 36,822 | 3,723,158 (8%) | 0% | 17.5 | 644,753 | Common Stock |
| SLR Investment Corp | Michael S. Gross | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 17.51 per share. | 04 Mar 2025 | 36,822 | 3,884,882 (9%) | 0% | 17.5 | 644,753 | Common Stock |
| SLR Investment Corp | Bruce J. Spohler | Director, See Remarks | Purchase of securities on an exchange or from another person at price $ 17.51 per share. | 04 Mar 2025 | 36,822 | 3,723,158 (8%) | 0% | 17.5 | 644,753 | Common Stock |
| Viatris | Corinne Le Goff | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 36,721 | 73,441 | - | - | Restricted Stock Units | |
| Viatris | Corinne Le Goff | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 36,721 | 36,721 (0%) | 0% | 0 | Common Stock | |
| Adaptive biotech Corp | Chad M. Robins | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 6.99 per share. | 04 Mar 2025 | 36,145 | 2,814,350 (2%) | 0% | 7.0 | 252,654 | Common Stock |
| Clarivate PLC | Gordon Samson | President, IP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 35,448 | 1,133,938 | - | 0 | Ordinary Shares | |
| Q2 Holdings Inc | John E. Breeden | Chief Delivery Officer | Sale of securities on an exchange or to another person at price $ 80.46 per share. | 04 Mar 2025 | 35,306 | 141,996 (0%) | 0% | 80.5 | 2,840,721 | Common Stock |
| Crexendo Inc | Jon Brinton | Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 35,000 | 35,000 | - | - | Restricted Stock Units | |
| enCore Energy Corp | William M. Sheriff | Director, Executive Chairman | Purchase of securities on an exchange or from another person at price $ 2.90 per share. | 04 Mar 2025 | 35,000 | 37,879 | - | 2.9 | 101,423 | Common Stock |
| enCore Energy Corp | William M. Sheriff | Director, Executive Chairman | Purchase of securities on an exchange or from another person at price $ 1.65 per share. | 04 Mar 2025 | 35,000 | 2,155,055 | - | 1.6 | 57,694 | Common Stock |
| enCore Energy Corp | William M. Sheriff | Director, Executive Chairman | 04 Mar 2025 | 35,000 | 37,876 | - | 1.4 | 48,300 | Common Stock | |
| Varonis Systems Inc | Greg Pomeroy | SVP, Worldwide Sales | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.97 per share. | 04 Mar 2025 | 34,777 | 215,144 (0%) | 0% | 43.0 | 1,494,368 | Common Stock, par value $0.001 per share |
| Rimini Street Inc | David W. Rowe | CPO,CMO&EVPGlob.Transformation | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 34,482 | 34,482 | - | - | Restricted Stock Units | |
| Rimini Street Inc | Nancy Lyskawa | EVP & Chief Client Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 34,482 | 34,482 | - | - | Restricted Stock Units | |
| Rimini Street Inc | Kevin Maddock | EVP,ChiefRecurringRev.Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 34,482 | 34,482 | - | - | Restricted Stock Units | |
| Rimini Street Inc | Steven Hershkowitz | EVP & Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 34,482 | 34,482 | - | - | Restricted Stock Units | |
| NextNRG Inc | Daniel Arbour | Director | Grant, award, or other acquisition of securities at price $ 3.81 per share. | 04 Mar 2025 | 34,121 | 103,362 | - | 3.8 | 130,001 | Common Stock, par value $0.0001 per share |
| NextNRG Inc | Sean Oppen | Director | Grant, award, or other acquisition of securities at price $ 3.81 per share. | 04 Mar 2025 | 34,121 | 88,835 | - | 3.8 | 130,001 | Common Stock, par value $0.0001 per share |
| NextNRG Inc | Daniel Arbour | Director | Grant, award, or other acquisition of securities at price $ 3.81 per share. | 04 Mar 2025 | 34,121 | 61,818 | - | 3.8 | 130,001 | Common Stock, par value $0.0001 per share |
| NextNRG Inc | Jack Leibler | Director | Grant, award, or other acquisition of securities at price $ 3.81 per share. | 04 Mar 2025 | 34,121 | 56,007 | - | 3.8 | 130,001 | Common Stock, par value $0.0001 per share |
| NextNRG Inc | Sean Oppen | Director | Grant, award, or other acquisition of securities at price $ 3.81 per share. | 04 Mar 2025 | 34,121 | 56,007 | - | 3.8 | 130,001 | Common Stock, par value $0.0001 per share |
| ACV Auctions Inc (Class A) | William R. Zerella | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 14.83 per share. | 04 Mar 2025 | 34,046 | 794,664 | - | 14.8 | 504,902 | Class A Common Stock |
| ACV Auctions Inc (Class A) | Vikas Mehta | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 14.83 per share. | 04 Mar 2025 | 34,046 | 517,124 | - | 14.8 | 504,902 | Class A Common Stock |
| ACV Auctions Inc (Class A) | Michael Waterman | Chief Sales Officer | Grant, award, or other acquisition of securities at price $ 14.83 per share. | 04 Mar 2025 | 33,960 | 356,915 | - | 14.8 | 503,627 | Class A Common Stock |
| Surgery Partners Inc | David T. Doherty | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 23.80 per share. | 04 Mar 2025 | 33,613 | 142,475 (0%) | 0% | 23.8 | 799,989 | Common Stock |
| Teva- pharma Ind Ltd (ADR) | Mark Sabag | See "Remarks" | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 33,512 | 263,376 (0%) | 0% | - | Ordinary Shares | |
| Teva- pharma Ind Ltd (ADR) | Mark Sabag | See "Remarks" | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 33,512 | 33,512 | - | - | Restricted Share Units | |
| Teva- pharma Ind Ltd (ADR) | Richard Daniell | Exec. VP, European Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 33,512 | 33,512 (0%) | 0% | - | Ordinary Shares | |
| Teva- pharma Ind Ltd (ADR) | Richard Daniell | Exec. VP, European Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 33,512 | 33,512 | - | - | Restricted Share Units | |
| Teva- pharma Ind Ltd (ADR) | Eli Kalif | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 33,512 | 231,253 (0%) | 0% | - | Ordinary Shares | |
| Teva- pharma Ind Ltd (ADR) | Eli Kalif | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 33,512 | 33,512 | - | - | Restricted Share Units | |
| Ridgepost Capital Inc | Nell M. Blatherwick | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 33,392 | 151,076 | - | 0 | Class A Common Stock | |
| Ridgepost Capital Inc | Nell M. Blatherwick | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 33,392 | 0 | - | - | Restricted Stock Unit | |
| Encompass Health Corp | Mark J. Tarr | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 33,086 | 33,086 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Apple Hospitality REIT Inc | Glade M. Knight | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 14.48 per share. | 04 Mar 2025 | 33,036 | 675,026 (0%) | 0% | 14.5 | 478,361 | Common Shares |
| Marriott Vacations Worldwide Corp | John E. Geller | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 32,858 | 56,877 (0%) | 0% | 0 | Common Stock | |
| Nexstar Media Grp Inc | Perry A. Sook | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 168.66 per share. | 04 Mar 2025 | 32,824 | 773,195 (1%) | 0% | 168.7 | 5,535,965 | Common Stock |
| Apple Hospitality REIT Inc | Nelson G. Knight | President Real Estate & Invest | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 32,799 | 979,783 (0%) | 0% | 0 | Common Shares | |
| Ligand Pharma Inc (Class B) | Octavio Espinoza | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 32,717 | 32,717 | - | - | Employee Stock Option (right to buy) | |
| General Dynamics | Phebe N. Novakovic | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 263.48 per share. | 04 Mar 2025 | 32,695 | 769,607 (0%) | 0% | 263.5 | 8,614,609 | Common Stock |
| Rayonier Advanced Materials Inc | Marcus J. Moeltner | CFO and SVP, Finance | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.48 per share. | 04 Mar 2025 | 32,523 | 172,139 (0%) | 0% | 7.5 | 243,272 | Common Stock |
| Apple Hospitality REIT Inc | Elizabeth S. Perkins | SVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 32,484 | 392,139 (0%) | 0% | 0 | Common Shares | |
| EQT | Robert R. Wingo | EVP CORP VENTURES & MIDSTREAM | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.00 per share. | 04 Mar 2025 | 32,385 | 262,670 (0%) | 0% | 50 | 1,619,250 | Common Stock |
| General Dynamics | Marguerite Amy Gilliland | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 32,220 | 32,220 | - | - | Stock Options | |
| Avanos Medical Inc | Joseph F. Woody | Former Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 32,158 | 453,203 (0%) | 0% | 0 | Common Stock | |
| Pegasystems Inc | Alan Trefler | Chief of Clients and Markets | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 32,145 | 32,145 | - | - | Stock Options | |
| Pegasystems Inc | John Gerard Higgins | Chief, Client &Partner Success | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 32,145 | 32,145 | - | - | Stock Options | |
| Pegasystems Inc | Kerim Rifat Akgonul | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 32,145 | 32,145 | - | - | Stock Options | |
| Nexstar Media Grp Inc | Perry A. Sook | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 170.67 per share. | 04 Mar 2025 | 32,096 | 806,019 (1%) | 0% | 170.7 | 5,477,690 | Common Stock |
| Callaway Golf Co | Oliver G. Brewer | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Mar 2025 | 31,905 | 181,153 (0%) | 0% | 0 | Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.